The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2024

Filed:

Apr. 17, 2020
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Vinod Jaskula-Ranga, Cambridge, MA (US);

Donald Zack, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/85 (2006.01); C12N 15/113 (2010.01); C12N 15/63 (2006.01); C12N 15/90 (2006.01); C12N 15/11 (2006.01); C12N 15/861 (2006.01); C12N 15/86 (2006.01); C12Q 1/68 (2018.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); C12N 15/111 (2013.01); C12N 15/1138 (2013.01); C12N 15/63 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); C12N 15/8616 (2013.01); C12N 15/907 (2013.01); C07K 2319/10 (2013.01); C07K 2319/60 (2013.01); C12N 2310/10 (2013.01); C12N 2310/20 (2017.05); C12N 2330/51 (2013.01); C12N 2750/14133 (2013.01); C12N 2750/14143 (2013.01); C12N 2830/205 (2013.01); C12N 2830/85 (2013.01);
Abstract

The presently disclosed subject matter provides compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter. In particular, compositions and methods are provided for the use of the H1 promoter to express CRISPR guide RNA (gRNA) with altered specificity of the 5′ nucleotide, as well as use of the H1 promoter sequence as a bidirectional promoter to express Cas9 nuclease and the gRNA simultaneously. Compositions and methods are also provided for the expression and regulation of gRNA expression in vivo through the use of RNA ribozymes and regulatable aptazymes.


Find Patent Forward Citations

Loading…